Bigot, Pierre <br/><br/>
Neoadjuvant targeted molecular therapies in patients undergoing nephrectomy and inferior vena cava thrombectomy: is it useful?  [electronic resource] 

 -  World journal of urology  Feb 2014 
 - 109-14 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1433-8726 
<br/><br/><label>Standard No.: </label>10.1007/s00345-013-1088-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--therapeutic use<br/>Carcinoma, Renal Cell--epidemiology<br/>Combined Modality Therapy<br/>Comorbidity<br/>Dose-Response Relationship, Drug<br/>Female<br/>France<br/>Humans<br/>Indoles--therapeutic use<br/>Kidney Neoplasms--epidemiology<br/>Male<br/>Middle Aged<br/>Molecular Targeted Therapy<br/>Neoadjuvant Therapy<br/>Nephrectomy<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds--therapeutic use<br/>Pyrroles--therapeutic use<br/>Retrospective Studies<br/>Sorafenib<br/>Sunitinib<br/>Thrombectomy<br/>Thrombosis--epidemiology<br/>Treatment Outcome<br/>Vena Cava, Inferior--surgery